Plasma endothelinlike immunoreactivity levels in IDDM patients with microalbuminuria.
OBJECTIVE
To determine whether plasma endothelin, a potent vasoconstrictor and growth factor for vascular smooth muscle, is elevated in microalbuminuric insulin-dependent diabetes mellitus patients.


METHODS
Plasma endothelinlike immunoreactivity was measured by radioimmunoassay in 15 microalbuminuric diabetic patients, 12 normoalbuminuric diabetic patients, and 12 control subjects.


RESULTS
The mean levels of plasma endothelinlike immunoreactivity were raised in the normoalbuminuric patients (8.4 pM [range 4.8-12.7 pM]; P less than 0.01) and the microalbuminuric patients (10.2 pM [range 5.6-31.1 pM]; P less than 0.001) compared with control subjects (6.1 pM [range 4.5-7.6 pM]). Plasma endothelinlike immunoreactivity was also higher in the microalbuminuric patients compared with the normoalbuminuric patients (P less than 0.05).


CONCLUSIONS
The increase in plasma endothelinlike immunoreactivity further confirms endothelial dysfunction in diabetes and this increase in plasma endothelin may contribute to the vascular disease prevalent in diabetes.
Collier
A
A
Diabetic Unit, Gart-Navel General Hospital, Glasgow, UK.
Leach
J P
JP
McLellan
A
A
Jardine
A
A
Morton
J J
JJ
Small
M
M
D000328:Adult; D000419:Albuminuria; D001786:Blood Glucose / Q000378:metabolism; D003922:Diabetes Mellitus, Type 1 / Q000097:blood* / Q000652:urine; D016232:Endothelins / Q000097:blood*; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D008875:Middle Aged; D011863:Radioimmunoassay; D012016:Reference Values; D012044:Regression Analysis
D001786:Blood Glucose; D016232:Endothelins; D006442:Glycated Hemoglobin